These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4722913)

  • 21. Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
    De Vita VT; Canellos GP; Schein PJ; Chabner BA; Bagley CM; Young RC
    Proc Natl Cancer Conf; 1972; 7():379-90. PubMed ID: 4587651
    [No Abstract]   [Full Text] [Related]  

  • 22. [Vinblastine + procarbazine + cyclophosphamide association in the treatment of Hodgkin's disease (author's transl)].
    Chauvergne J; Hoerni B; Hoerni-Simon G; Durand M; Lagarde C
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1973 Nov; 80(2):179-88. PubMed ID: 4271955
    [No Abstract]   [Full Text] [Related]  

  • 23. The sensitivity of Hodgkin's disease to chemotherapeutic agents administered singly.
    Desser RK; Ultmann JE
    Ser Haematol; 1973; 6(2):152-81. PubMed ID: 4131662
    [No Abstract]   [Full Text] [Related]  

  • 24. BCNU, velban, cyclophosphamide, procarbazine, and prednisone (BVCPP) in advanced Hodgkin's disease.
    Durant JR; Gams RA; Velez-Garcia E; Bartolucci A; Wirtschafter D; Dorfman R
    Cancer; 1978 Nov; 42(5):2101-10. PubMed ID: 719600
    [No Abstract]   [Full Text] [Related]  

  • 25. Combination chemotherapy in malignant diseases.
    Fairley GH
    J R Coll Physicians Lond; 1971 Jan; 5(2):167-77. PubMed ID: 4950464
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemotherapy for advanced Hodgkin's disease: conclusions from the Southeastern Cancer Study Group.
    Gams RA; Durant JR; Bartolucci AA
    Cancer Treat Rep; 1982 Apr; 66(4):899-905. PubMed ID: 7042089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCNU (NSC-409962) in the treatment of advanced Hodgkin's disease, lymphosarcoma, and reticulum cell sarcoma.
    Rege VB; Owens AH
    Cancer Chemother Rep; 1974; 58(3):383-92. PubMed ID: 4601668
    [No Abstract]   [Full Text] [Related]  

  • 28. Status and perspectives in chemotherapy of Hodgkin's disease.
    Frei E
    Arch Intern Med; 1973 Mar; 131(3):439-45. PubMed ID: 4739436
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology group.
    Glick JH; Barnes JM; Bakemeier RF; Prosnitz LR; Bennett JM; Neiman RS; Costello W; Orlow EL
    Cancer Treat Rep; 1982 Apr; 66(4):855-70. PubMed ID: 7042087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
    Frei E; Schabel FM; Goldin A
    Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
    [No Abstract]   [Full Text] [Related]  

  • 31. BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
    Durant JR; Gams RA; Bartolucci AA; Dorfman RF
    Cancer Treat Rep; 1977 Sep; 61(6):1085-96. PubMed ID: 332345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter: Chemotherapy of Hodgkin's disease.
    Winokur SH
    N Engl J Med; 1974 Dec; 291(24):1309. PubMed ID: 4431438
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease.
    Bartolucci AA; Liu C; Durant JR; Gams RA
    Cancer; 1983 Dec; 52(12):2209-13. PubMed ID: 6580060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
    McElwain TJ; Wrigley PF; Hunter A; Crowther D; Malpas JS; Peckham MJ; Smithers DW; Fairley GH
    Natl Cancer Inst Monogr; 1973 May; 36():395-402. PubMed ID: 4744597
    [No Abstract]   [Full Text] [Related]  

  • 35. Combination chemotherapy in Hodgkin's disease.
    Nordentoft AM; Jensen KB
    Dan Med Bull; 1973 Mar; 20(2):52-60. PubMed ID: 4688460
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
    Boiron M; Teillet F; Weisgerber C; Dana M; Jacquillat C; Bernard J
    Rev Prat; 1974 Oct; 24(45):3971-8. PubMed ID: 4445767
    [No Abstract]   [Full Text] [Related]  

  • 37. Oat cell carcinoma of the lung: combination chemotherapy with cyclophosphamide, vincristine and procarbazine.
    Wittes RE; Hopfan S; Wittes JT; Golbey RB; Martini N
    Clin Bull; 1977; 7(1):21-4. PubMed ID: 212216
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term follow-up of two chemotherapy protocols in Hodgkin's disease.
    Pavlovsky S; Morgenfeld M; Somoza N; Magnasco J; Sackmann Muriel F; Cavagnaro F; Suárez A; Barros CA; Saslavsky J; Garay G; Palau M; Besuschio SC
    Medicina (B Aires); 1981; 41 Suppl():15-21. PubMed ID: 6896551
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment strategy of Hodgkin lymphoma].
    Nagai H
    Rinsho Ketsueki; 2014 Oct; 55(10):1941-51. PubMed ID: 25297759
    [No Abstract]   [Full Text] [Related]  

  • 40. Low dose radiation therapy and combination chemotherapy in the treatment of advanced Hodgkin's disease.
    Prosnitz LR; Farber LR; Fischer JJ; Bertino JR
    Radiology; 1973 Apr; 107(1):187-93. PubMed ID: 4689429
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.